Abeona Therapeutics Inc. (ABEO)

NASDAQ: ABEO · USD

$4.56

+0.11 (+2.4%)· Recorded snapshot

Market cap	260.5M
Revenue (ttm)	25.5M
Net income (ttm)	-62.9M
EPS (ttm)	-$1.18
Shares out	57.2M
Volume	504,452
Beta	1.30

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 25.5M
Net income (ttm): -62.9M
EPS (ttm): -$1.18
Market cap: 260.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-43.1

P25 n/aP50 n/aP75 n/a

ROIC-31.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ABEO indicators

Market & fundamental data

Available fields

216

Groups with data

Currency

USD

Showing 216 of 216 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000318306
Company name	Abeona Therapeutics Inc.
Country	United States
Country code	US
CUSIP number	00289Y206
Earnings date	2026-11-11
Earnings time	bmo
Employees	226
Employees change	90
Employees growth	66.18%
Enterprise value	$133.5M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1974
In index	RUSSELL2000
Industry	Biotechnology
IPO date	1980-09-19
Is primary listing	Yes
Is SPAC	No
ISIN number	US00289Y2063
Last 10-K release date	2026-03-17
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2022-07-05
Last stock split type	Reverse
Market cap	$260.5M
Market cap category	Micro-Cap
Next earnings date	2026-11-11
Options	Yes
Price	$4.56
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ABEO
U.S. state	Ohio
Website	https://www.abeonatherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-25.99%
EV/Sales	5.06x
FCF / EV yield	-63.09%
FCF yield	-31.82%
Forward EV/Sales	1.64x
Forward P/S	3.24x
P/B ratio	1.99x
P/S ratio	10.04x
Price / tangible book value	2x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-39.9%
Operating margin	-327.64%
Pretax margin	-306.81%
Profit margin	-246.42%
Profit per employee	$-278,261
Profitable years	1
Revenue per employee	$112,920
ROA	-24.55%
ROA (5Y)	-39.57%
ROCE	-54.05%
ROE	-43.13%
ROE (5Y)	-127.84%
ROIC	-31.15%
SBC / revenue	45.35%
Tax / revenue	-60.38%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	6
Net income growth years	1
Revenue growth	6,280%
Revenue growth (Q)	2,745%
Revenue growth (QoQ)	30.5%
Revenue growth 10Y	38.98%
Revenue growth 3Y	92.67%
Revenue growth 5Y	20.61%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-5.1M
Depreciation and amortization	$2.8M
EBIT	$-83.6M
EBITDA	$-80.8M
EPS	$-1.18
FCF per share	$-1.43
Financing cash flow	$3.2M
Free cash flow	$-81.5M
Free cash flow minus SBC	$-93.1M
Gross profit	$-10.2M
Income taxes	$-15.4M
Investing cash flow	$-34.4M
Net borrowing	$-5.6M
Net cash flow	$-107.6M
Net income	$-62.9M
Operating cash flow minus SBC	$-88M
Operating income	$-83.6M
Revenue	$25.5M
Stock-based compensation	$11.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-3.11
Book value per share	$2.24
Debt / equity	0.16
Interest coverage	-25.25
Long-term assets	$14.9M
Long-term liabilities	$26.6M
Net cash (debt)	$127M
Net cash / market cap	49.56%
Net cash growth	-36.98%
Net debt / equity	-0.99
Piotroski F-Score	3
Property, plant and equipment	$14.1M
Shareholders' equity	$128.1M
Tangible book value	$128.1M
Tangible book value per share	$2.24
Total assets	$179.5M
Total cash	$146.8M
Total debt	$19.9M
Total liabilities	$51.4M
WACC	11.53%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.12
Current assets	$164.6M
Current liabilities	$24.8M
Current ratio	6.63
Inventory turnover	8.3
Net working capital	$7.6M
Quick ratio	6.32
Working capital	$139.8M
Working capital turnover	0.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.73%
Dividend yield	0%
Shareholder yield	1.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-97.5%
10Y return CAGR	-30.86%
10Y total return	-97.5%
150-day SMA	$5.66
15Y price change	-99.79%
15Y return CAGR	-33.77%
15Y total return	-99.79%
1D price change	2.36%
1M price change	-16.11%
1M total return	-16.11%
1W price change	-1.52%
1W total return	-1.52%
1Y price change	-18.23%
1Y return CAGR	-18.24%
1Y total return	-18.23%
20-day SMA	$4.68
200-day SMA	$5.50
20Y price change	-99.67%
20Y return CAGR	-24.86%
20Y total return	-99.67%
3M price change	-26.1%
3M total return	-26.1%
3Y price change	22.1%
3Y return CAGR	6.88%
3Y total return	22.1%
50-day SMA	$5.31
50-day SMA vs 200-day SMA	50under200
52-week high	$7.65
52-week high date	2026-08-11
52-week low	$4.00
52-week low date	2025-11-07
5Y price change	-78.68%
5Y return CAGR	-26.59%
5Y total return	-78.68%
6M price change	-15.17%
6M total return	-15.17%
All-time high	$343,750.00
All-time high date	1996-03-08
All-time low	$2.19
All-time low date	2023-02-24
Average true range (ATR)	$0.21
Average volume	1.1M
Beta (1Y)	2.66
Beta (2Y)	1.59
Beta (5Y)	1.3
Change from 52-week high	-40.46%
Change from 52-week low	13.88%
Change from all-time high	-100%
Change from all-time low	106.85%
Change from open	2.36%
Day's gap	0%
Dollar volume	$2.3M
High price	$4.58
Low price	$4.44
Monthly RSI	41.2
Open price	$4.45
Position in 52-week range	85.19%
Premarket change	0.79%
Premarket close	$4.45
Premarket price	$4.49
Premarket volume	4K
Previous close	$4.45
Price vs 150-day SMA	-19.94%
Price vs 20-day SMA	-3.29%
Price vs 200-day SMA	-17.64%
Price vs 50-day SMA	-14.62%
Relative volume	0.46
RSI	40.15
Sharpe ratio	-0.18
Sharpe ratio (3Y)	0.38
Sharpe ratio (5Y)	-0.04
Sortino ratio	-0.15
Sortino ratio (3Y)	0.62
Sortino ratio (5Y)	0.01
Volume	504.5K
Weekly RSI	39.31
YTD price change	-14.04%
YTD total return	-14.04%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	36.1M
Float percentage	63.12%
Shares change (QoQ)	0.75%
Shares change (YoY)	-1.73%
Shares held by insiders	17.42%
Shares held by institutions	49.83%
Shares outstanding	57.2M
Short % of float	47.7%
Short % of shares	30.1%
Short ratio	12.2 days

Deeper analysis on ABEO

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ABEO report

Is a complete ABEO research report available?

No complete published report is available for Abeona Therapeutics Inc. (ABEO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Abeona Therapeutics Inc. (ABEO)

Price

Financial snapshot

Fair-value bridge

Latest news · ABEO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ABEO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ABEO

Frequently asked questions